 EMERYVILLE, Calif., May 03, 2021 GLOBE NEWSWIRE -- XOMA Corporation Nasdaq: XOMA XOMA or the Company today announced it has earned a 0.5 million milestone from Janssen Biotech, Inc. Janssen, as a result of the first patient dosed in a Phase 3 clinical trial evaluating one of Janssens biologic assets. 